These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24980949)

  • 1. EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein.
    Hristodorov D; Amoury M; Mladenov R; Niesen J; Arens K; Berges N; Hein L; Di Fiore S; Pham AT; Huhn M; Helfrich W; Fischer R; Thepen T; Barth S
    Mol Cancer Ther; 2014 Sep; 13(9):2194-202. PubMed ID: 24980949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
    Amoury M; Mladenov R; Nachreiner T; Pham AT; Hristodorov D; Di Fiore S; Helfrich W; Pardo A; Fey G; Schwenkert M; Thepen T; Kiessling F; Hussain AF; Fischer R; Kolberg K; Barth S
    Int J Cancer; 2016 Aug; 139(4):916-27. PubMed ID: 27037627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.
    Hristodorov D; Nordlohne J; Mladenov R; Huhn M; Fischer R; Thepen T; Barth S
    Br J Haematol; 2014 Jan; 164(2):251-7. PubMed ID: 24164493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, expression, and characterization of a recombinant immunotoxin targeting EpCAM.
    Lv M; Qiu F; Li T; Sun Y; Zhang C; Zhu P; Qi X; Wan J; Yang K; Zhang K
    Mediators Inflamm; 2015; 2015():460264. PubMed ID: 25960617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Immunotoxin Targeting Epithelial Cell Adhesion Molecule Using Single Domain Antibody Fused to Diphtheria Toxin.
    Roshan R; Naderi S; Behdani M; Ahangari Cohan R; Kazemi-Lomedasht F
    Mol Biotechnol; 2023 Apr; 65(4):637-644. PubMed ID: 36129635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.
    Ruf P; Gires O; Jäger M; Fellinger K; Atz J; Lindhofer H
    Br J Cancer; 2007 Aug; 97(3):315-21. PubMed ID: 17622246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.
    Hristodorov D; Mladenov R; Pardo A; Pham AT; Huhn M; Fischer R; Thepen T; Barth S
    Br J Cancer; 2013 Sep; 109(6):1570-8. PubMed ID: 23942071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.
    Vorobyeva A; Konovalova E; Xu T; Schulga A; Altai M; Garousi J; Rinne SS; Orlova A; Tolmachev V; Deyev S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer.
    Connor JP; Felder M; Hank J; Harter J; Gan J; Gillies SD; Sondel P
    J Immunother; 2004; 27(3):211-9. PubMed ID: 15076138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ganglioside expression and anti-cancer effects of the monoclonal antibody against epithelial cell adhesion molecule in colon cancer.
    Kwak DH; Ryu JS; Kim CH; Ko K; Ma JY; Hwang KA; Choo YK
    Exp Mol Med; 2011 Dec; 43(12):693-701. PubMed ID: 22033101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
    Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
    Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-derived EpCAM antigen induces protective anti-cancer response.
    Brodzik R; Spitsin S; Golovkin M; Bandurska K; Portocarrero C; Okulicz M; Steplewski Z; Koprowski H
    Cancer Immunol Immunother; 2008 Mar; 57(3):317-23. PubMed ID: 17634938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.
    Kosterink JG; McLaughlin PM; Lub-de Hooge MN; Hendrikse HH; van Zanten J; van Garderen E; Harmsen MC; de Leij LF
    J Immunol; 2007 Jul; 179(2):1362-8. PubMed ID: 17617629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM.
    Deng Z; Wu Y; Ma W; Zhang S; Zhang YQ
    BMC Immunol; 2015 Jan; 16(1):1. PubMed ID: 25636521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
    Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
    Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.